Fosamax Class Action Attorneys Blog

Based on present findings on osteoporosis-related studies, it is believed that there is no immediate and magic-pill equivalent for treating this chronic and debilitating disease, medical experts say. Yet the problem with much of modern medicine and pharmacology today, according to most experts, is that aggressive marketing campaigns have led many to the belief that there is a “pill for every ill”. Some experts speculate that this pill-popping attitude has led to the legal compensation problems facing consumers, drug manufacturers and legislators today.

While there is certainly some truth in the effectiveness of the medications available in the market, this culture of “pill popping” has led to what some experts would call an over-dependence on medication prescriptions. They note that people in today’s demanding and fast paced society have grown lazy and apathetic towards treatment options, thinking that choosing the most expedient methods (which often involves taking some type of pill or another to manage their illnesses) is all they need, which is a common misconception of therapy. This problem is compounded even more with doctors in the medical community working with pharmaceutical companies that are only too eager to provide the supply for the demand.

Proper medical therapy is a complicated process involving diagnosis, planning, treatment, and evaluation in which half of the effort is dependent on the patient’s compliance in order to be truly effective. Most often a patient’s economic situation, financial status, societal influences and personal preferences interfere with that process. It also doesn’t help that heavy consumerism is promoted by many of the big pharmaceutical companies when a new disease condition is discovered; a new drug for managing it is not far behind. An example in this case is how osteopenia is regarded within the medical community.

In the long run, physicians and patients should always consider their treatment options carefully and rationally and hopefully, choosing the best therapy suited to their needs. The current situation over Merck’s Fosamax litigation trials and how bisphosphonates have been marketed to the public is a prime example of how a company’s motivation for profit overshadows its moral responsibilities to provide safe and informed medical treatment options to their consumers and patients. Avoiding situations resulting from the myth of “magic pills” should help to maintain good faith between manufacturers and consumers and help to promote relations and good health with those involved in the medical community.

For more information on Fosamax class action lawsuit, there are online blogs with updates and information available for your perusal.